DENTALKART (DENTALKART) fundamentals
DENTALKART is a listed company, part of the Trading sector, listed on the NSE as DENTALKART (ISIN INE0N5801013). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What DENTALKART does
Vasa Denticity Limited is an India-based company, which is engaged in supplying a range of dental products, instruments, equipment, and consumables to dental clinics, hospitals, and practitioners across India. It provides comprehensive dental commerce and technology platforms, purpose-built to serve the full spectrum of needs for oral-care professionals. The Company offers over 22,000 dental products and has onboarding of approximately 468 brands. It provides Nasal Drops/Spray, Local Anesthesia, Analgesics, Antipyretics & Anti-Inflammatory, Vitamins & Supplements, Antibiotics. Its brands are OrthoMetric, GC, Dentsply, Waldent, SuperEndo, Waldent AlChem, ET Dental, Mani, GDC, Woodpecker. Its subsidiaries include Waldent Innovations Private Limited and Smileworks Private Limited. The Company is engaged in the business of manufacturing, processing, exporting, importing, distributing, and trading a range of surgical instruments, diagnostic equipment, and medical devices.
Valuation and market data
| Last close | ₹390.00 |
|---|---|
| Market capitalisation | ₹631 crore |
| Enterprise value | ₹627 crore |
| P/E (TTM) | 0.00 |
| Price to book | 4.72 |
| Price to sales (TTM) | 2.06 |
| Book value per share | ₹82.64 |
| Dividend yield | 0.00% |
| Sector | Trading |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹283 crore | ₹13 crore | ₹10 crore | 0.00 |
| Mar 2025 | ₹251 crore | ₹23 crore | ₹17 crore | 10.45 |
| Mar 2024 | ₹173 crore | ₹19 crore | ₹15 crore | 9.72 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 60.2% |
|---|---|
| Foreign institutions (FII) | 6.9% |
| Mutual funds | 0.3% |
| Other domestic institutions | 1.9% |
| Retail and others | 30.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.